Partnering with Johnson & Johnson: Understand the Why, How, What & Needs
Apr 27, 2021 1:00PM—2:00PM
Categories Biopharma & Therapeutics, Emerging Companies, Industry Partner Event, Industry Partner Events
Join Temple Health and Bioscience District for our April E-Learning Series Webinar
About this Event
Johnson & Johnson (J&J) is focused on changing the trajectory of healthcare for humanity for the better. To accomplish this vision, J&J explores both organic and inorganic innovations. During this presentation, Ibraheem Badejo, Ph.D. and Senior Director of New Ventures at J&J, will detail external innovation strategies for engaging with early-stage companies to design transformative healthcare solutions. Badejo leverages his expertise in smart materials and biomaterials to support the medical device sector of J&J. During his career, he has led teams in the development of commercialized biomaterials-based products and new technology products licensed or acquired. He is the recipient of 24 U.S. patents and is well-published in peer review journals. Join us to glean insight from his expertise.
About the Speaker:
Ibraheem (Ib) leverages his expertise in smart materials and biomaterials to support the medical device sector of Johnson & Johnson. From 2010 to 2013, Ib was a Research Fellow at Global Surgery Group of Johnson & Johnson, where he was responsible for external and front-end innovations and intellectual property for Ethicon Biosurgery. From 2006 to 2010, he was the Director of Applied Research & New Technology Assessment of novel biomaterials. Prior to that, he was the Chief Scientist of Closure Medical Corp (acquired by Johnson & Johnson in 2005). Ib has held various positions at Bayer, North Carolina State University, and the College of Charleston. He currently serves as an Adjunct Professor of Biomedical Engineering at Drexel University.
During his career, Ibraheem has led teams in the development of commercialized biomaterials-based products and new technology / products licensed or acquired. Ib received his PhD in organic chemistry from the University of Toledo, where he was the Robert Whiteford Memorial Scholar for Outstanding Graduate Research and a Petroleum Research Fund Fellow. Ib received the Science Alumni Award, Avila University in 2014. Ib will be receiving the 2020 Distinguished Alumni Award (College of Natural Sciences and Mathematics) from the University of Toledo in 2021. Ib is also the recipient of 24 US patents, he’s also well published in many peer review journals.
Ib spends some of his spare time meeting the needs of others and giving back to the world. He has participated and led mission trips – rural North Carolina, Mexico, Kenya, Haiti, Trinidad and Tobago. He currently serves as board of trustee of Avila University, board member of MedShare – a not for profit medical mission organization, Visiola Foundation, member of the executive committee and board member of Southeast Medical Device Association (SEMDA), Massachusetts Medical Device Development Center (M2D2). He also supports Coulter Foundation Programs at Georgia Tech / Emory Univ, Drexel Univ, Univ of Michigan, Univ of Pittsburgh and the Science Center – QED Program, John Hopkins Thalheimer Fund Investment on advisory board role.